• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Charles River Laboratories Intl (NY: CRL )

    191.81 -4.17 (-2.13%)
    Streaming Delayed Price Updated: 1:53 PM EDT, Oct 2, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 244,147
    Open 195.42
    Bid (Size) 191.65 (4)
    Ask (Size) 192.00 (4)
    Prev. Close 195.98
    Today's Range 191.17 - 195.42
    52wk Range 181.22 - 262.00
    Shares Outstanding 50,396,622
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage Biocluster
    From Charles River Laboratories International, Inc.
    Via Business Wire

    Performance

    YTD
    -12.17%
    -12.17%
    1 Month
    -8.50%
    -8.50%
    3 Month
    -8.08%
    -8.08%
    6 Month
    -4.22%
    -4.22%
    1 Year
    -5.88%
    -5.88%

    More News

    Read More
    Charles River Laboratories International, Inc. (NYSE: CRL) Long Term Investor Alert: Investigation of Potential Wrongdoing
    Via SBWire
    What 5 Analyst Ratings Have To Say About Charles River
    Via Benzinga
    Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Charles River Laboratories to Host Virtual Investor Day
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Steer Clear of Outrageously Valued VinFast Stock. 3 EV Stocks to Buy Instead.
    Via InvestorPlace
    Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods
    From Charles River Laboratories International, Inc.
    Via Business Wire
    WeWork's Journey From $47B Valuation To Possible Bankruptcy, Mastercard and Visa Reassess Ties with Binance Card, Hawaiian Electric Accused Of Jeopardizing Investigation Of Maui Wildfires: Today's Top Stories
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    Endangered Horseshoe Crabs Vital In Medical Research, Charles River Lab Commits To Enhanced Protection
    Via Benzinga
    Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon
    From Charles River Laboratories International, Inc.
    Via Business Wire
    CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    B of A Securities Maintains Buy Rating for Charles River: Here's What You Need To Know
    Via Benzinga
    US Stocks Edge Lower; Charles River Earnings Top Estimates
    Via Benzinga
    Charles River Laboratories Announces Second-Quarter 2023 Results
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Lyft, Disney And 3 Stocks To Watch Heading Into Wednesday
    Via Benzinga
    Investor Sentiment Declines After Moody's Downgrades Credit Ratings Of Banks
    Via Benzinga
    Buy Alert: 3 Healthcare Stocks Nearing Super Attractive Entry Points
    Via InvestorPlace
    Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets
    From Charles River Laboratories International, Inc.
    Via Business Wire
    Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
    From Charles River Laboratories International, Inc.
    Via Business Wire
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    CRL FINAL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important July 18 Deadline in Securities Class Action – CRL
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, Charles River, and Virtu and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.